Skip to main navigation Skip to search Skip to main content

Copper(II) complexes of indolo[2,3-c]quinoline-derived Schiff bases: Insight into the mechanism of their antiproliferative activity

  • Felix Bacher*
  • , Christian Madejski
  • , Irina Kuznetcova
  • , Orsolya Dömötör
  • , Béla Gyurcsik
  • , Zeyad H. Nafaee
  • , Nóra Igaz
  • , Csenge Bocz
  • , Bálint Péntek
  • , Mónika Kiricsi
  • , Petra Raptova
  • , Alexandru-Constantin Stoica
  • , Michaela Hejl
  • , Michael A. Jakupec
  • , Samah Mutasim Alfadul
  • , Maria V. Babak
  • , Peter Rapta
  • , Jóhannes Reynisson
  • , Lenka Sindlerova
  • , Éva A. Enyedy*
  • Ernest Hamel, Vladimir B. Arion*
*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

Abstract

Indoloquinolines are potent anticancer agents, but their poor aqueous solubility prevents clinical development. Indoloquinoline-based metal complexes offer an opportunity to circumvent this drawback. A series of new indolo[2,3-c]quinoline derivatives HL1–HL8 and their copper(II) complexes were synthesized, comprehensively characterized and tested for antiproliferative activity against MDA-MB-231, MCF-7, MCF-7 KCR, A549 and DU-145 cancer cells and compared to known isomeric indolo[3,2-c]quinolines (HL11–HL14 and 11–14). The Cu(II) complexes were generally as active, or slightly more so, than the proligands. Lead compounds HL8 and 8 showed superior anticancer activity compared to isomers HL14 and 14, respectively. Complex 8 was superior to HL8 in ROS generation in A549 cells, induced mitochondrial dysfunction as evidenced by JC-1 staining, induced lactate dehydrogenase release in medium, inhibited DNA synthesis and triggered apoptosis. DNA-binding studies, supported by molecular docking calculations, showed strong affinity of the compounds for double stranded DNA, to which they bind by intercalation. © 2026 The Authors.
Original languageEnglish
Article number118882
Number of pages26
JournalEuropean Journal of Medicinal Chemistry
Volume315
Online published21 Apr 2026
DOIs
Publication statusOnline published - 21 Apr 2026

Funding

This work was funded by the Austrian Science Fund (FWF) grant no. P31293, by a grant from the Romanian National Authority for Research, project no. PNRR–III–C9-2023-I8-99 within the National Recovery and Resilience Plan, by the Slovak Research and Development Agency under contract nos APVV-23-0195, SK-HU-24-0003 (P. R.) and the grant agency VEGA (contract no. 1/0392/24), as well as by the National Research, Development and Innovation Office-NKFIA (Hungary) through projects TKP2021-EGA-32, K138318 and PharmaLab (RRF-2.3.1.-21-2022-00015). MTT experiments were performed using support from the City University of Hong Kong (Project No. 7005829).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'Copper(II) complexes of indolo[2,3-c]quinoline-derived Schiff bases: Insight into the mechanism of their antiproliferative activity'. Together they form a unique fingerprint.

Cite this